DRUG INTERACTIONS - ANTINEOPLASTICS

被引：3

|

作者：

HARTSHORN, EA

机构：

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1969年 / 3卷 / 07期

关键词：

D O I：

10.1177/106002806900300703

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：196 / +

页数：1

相关论文

共 50 条

[1] DRUG-INTERACTIONS AFFECTING ELIMINATION OF ANTICOAGULANTS AND ANTINEOPLASTICS
WOSILAIT, WD
RYAN, MP
BYINGTON, KH
FEDERATION PROCEEDINGS, 1981, 40 (03) : 639 - 639
[2] Intraperitoneal Drug Delivery of Antineoplastics
Maurie Markman
Drugs, 2001, 61 : 1057 - 1065
[3] Intraperitoneal drug delivery of antineoplastics
Markman, M
DRUGS, 2001, 61 (08) : 1057 - 1065
[4] Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics
Bossaer, John B.
Eskens, Danielle
Gardner, Austin
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (01) : 82 - 86
[5] Herbal medicines + antineoplastics: testing for interactions needed
Reactions Weekly, 2004, 1009 (1) : 3 - 3
[6] Antineoplastics/MethylprednisoloneLack of efficacy and acquired drug resistance
Reactions Weekly, 2024, 2014 (1) : 77 - 77
[7] Addressing potential interactions between antineoplastics and dietary supplements
Bossaer, John B.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (11) : 915 - 916
[8] Drug Interaction in Psycho-Oncology: Antidepressants and Antineoplastics
Miguel, C.
Albuquerque, E.
PHARMACOLOGY, 2011, 88 (5-6) : 333 - 339
[9] Antineoplastics/chloroquineLack of drug effect: 4 case reports
Reactions Weekly, 2022, 1894 (1) : 46 - 46
[10] Antineoplastics/oprelvekinExanthematous drug eruption and myelosuppression: case report
Reactions Weekly, 2017, 1656 (1) : 53 - 53

← 1 2 3 4 5 →